Yoshinori Komatsu

Title: Innovations of Yoshinori Komatsu

Introduction

Yoshinori Komatsu is a prominent inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel polypeptide derivatives. With a total of 7 patents to his name, his work has had a substantial impact on medical science.

Latest Patents

Among his latest patents, Yoshinori has developed a G-CSF conjugate, which includes novel hG-CSF polypeptide derivatives. These derivatives have an amino acid sequence derived from the human granulocyte colony-stimulating factor polypeptide, achieved by substituting or deleting amino acids. His patents also cover recombinant plasmids containing DNA fragments that code for these hG-CSF polypeptide derivatives, as well as microorganisms that carry such plasmids. Additionally, he has disclosed methods for producing these hG-CSF polypeptide derivatives using the microorganisms, along with a monoclonal antibody that binds to the hG-CSF polypeptide derivative. Furthermore, he has worked on chemically modified hG-CSF or its derivatives.

Career Highlights

Yoshinori Komatsu has had a distinguished career, working with notable companies such as Kyowa Hakko Kogyo Co., Ltd. and Kyowa Hakko Bio Co., Ltd. His expertise in biotechnology has allowed him to contribute to various innovative projects and advancements in the field.

Collaborations

Throughout his career, Yoshinori has collaborated with esteemed colleagues, including Tetsuro Kuga and Hiromasa Miyaji. These collaborations have further enhanced his research and development efforts.

Conclusion

Yoshinori Komatsu's innovative work in biotechnology, particularly in the development of hG-CSF polypeptide derivatives, showcases his significant contributions to medical science. His patents and collaborations reflect his dedication to advancing the field and improving healthcare solutions.